Showing results (571-580 of 3,148) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|November 2, 2021
DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncologyDrew Pratt, Felix Sahm, Kenneth Aldape
Neuro-Oncology|July 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma modelsRomain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.
Neuro-Oncology|July 22, 2022
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patientsRichard Drexler, Ulrich Schüller, Alicia Eckhardt, et al.
Neuro-Oncology|July 22, 2022
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasisFlorence Oberkampf, Maya Gutierrez, Olfa Trabelsi Grati, et al.
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Neuro-Oncology|January 27, 2016
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapyFrank Saran, Olivier L Chinot, Roger Henriksson, et al.
Neuro-Oncology|January 15, 2016
Von Hippel-Lindau disease: an evaluation of natural history and functional disabilityAlberto Feletti, Mariagiulia Anglani, Bruno Scarpa, et al.
Neuro-Oncology|January 31, 2016
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaMalak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, et al.
Neuro-Oncology|October 22, 2015
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphomaChan Yoon Cheah, Sarah Milgrom, Dai Chihara, et al.
Neuro-Oncology|September 30, 2015
Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literatureCristina Izquierdo, Roser Velasco, Noemí Vidal, et al.
Pageof 315